Last checked at 20 May 2020 07:00
On 19 May 2020, the Company was notified that the Viehbacher 2015 GRAT u/a/d 22 May 2015 (the 'Trust'), of which Mr Christopher Viehbacher (a Non-Executive Director and Chairman of the Company) is a Trustee, transferred, for nil consideration, 1,025,646 Ordinary Shares of one pence each in the Company to Mr Christopher Viehbacher to hold directly in his own name.
Following this transaction, Mr Christopher Viehbacher continues to have a holding of 1,025,646 Ordinary Shares, representing approximately 0.3% of the issued share capital of the Company.
This notification is made under Article 19 of the Market Abuse Regulation.
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a) | Name | The Viehbacher 2015 GRAT u/a/d 22 May 2015 | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Mr Christopher Viehbacher, a Director and the Chairman, is a Trustee of the above listed Trust | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | PureTech Health plc | ||||||||
b) | LEI | 213800LVPDNO2Z9T9I39 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code |
ISIN GB00BY2Z0H74 | ||||||||
b) | Nature of the transaction | A transfer of Ordinary Shares for nil consideration from The Viehbacher 2015 GRAT u/a/d 22 May 2015 to Mr Christopher Viehbacher, a Trustee of such Trust. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information
|
| ||||||||
e) | Date of the transaction | 19 May 2020 | ||||||||
f) | Place of the transaction | Outside of a trading venue | ||||||||